ClinicalTrials.govpublic full text
A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer
advanced cancer, tgf-beta, urothelial carcinoma, hepatocellular carcinoma, non-small cell lung cancer, tgf- beta receptor type i inhibitor, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887242
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.